NCT05964465View on ClinicalTrials.gov

Mechanisms of Smell Improvement With Dupilumab.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

Dupilumab

Monoclonal antibody blocking interleukin 4 and interleukin 13

Trial Locations (2)

22904

University of Virginia, Charlottesville

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER